Published Date: 08 Mar 2023
The latest data on metformin in COVID show benefits in the disease.
Read Full NewsEli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed better results in patients with the skin disease and obesity in a...
Patients with moderate‑to‑severe plaque psoriasis achieve greater relief from itching, skin pain, and scaling with bimekizumab vs secukinumab up to 3 years.
Treatment with amivantamab is associated with a broad spectrum of dermatologic adverse events that can be severe in patients with non-small cell lung cancer, a real-world study shows.
South Carolina reported a surge to 962 measles cases on Tuesday, state health data showed, including 12 additional infections since Friday, as officials warned the widening...
As currently written, the instructions could potentially lead to delayed treatment of high glucose levels.
An expansion of higher-level neonatal care has been observed in urban hospitals in the US over the years, whereas rural hospitals have faced a decline in such care capacity, per a recent study.
1.
Unraveling the role of exercise in cancer suppression
2.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
3.
Alkem introduces cetuximab under the trade name Cetuxa in India.
4.
Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer
5.
Survivors of childhood brain cancer are more likely to be held back in school
1.
Synovial Sarcoma of Female Urethra: Case Report and Literature Review
2.
Abemaciclib in Combination with Therapies for Patients with Metastatic Breast Cancer
3.
Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers
4.
Tertiary Lymphoid Structures in Cancer: Advancing Therapeutic Implications
5.
Understanding Melanoma: From Diagnosis to Healing and Excision in Denver
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
2.
Current Scenario of Cancer- Q&A Session to Close the Gap
3.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation